Your Global Outsourcing Experts

 

Meghan Stewart, Lead Project ManagerMeghan Stewart

Expertise: Accessing Special Patient Populations and Generic Drug Development

With knowledge of therapeutic areas, access to specific patient populations, and regulatory guidelines across numerous CROs worldwide, I can help to identify the best service provider for your study.  

In addition, I bring to the table knowledge of international contract service organizations such as CMOs, formulators, and preclinical labs.   I can help you to identify, qualify, and obtain quotations from CROs and CSOs that best fit your needs.

mstewart@pharmaservicesnet.com           +1 803 746 4095

 

 

Todd Tambling, Business Development ManagerTodd Tambling

Expertise: Phase 2 - 4 Clinical Trials

I help pharmaceutical and biotech sponsors find high quality, competent, and experienced Clinical Research Organizations to conduct their clinical trials.  Recently, I worked with a sponsor who was facing serious challenges with patient recruitment on a global phase 3 study.  Utilizing my knowledge of the industry and our extensive network, I was able to help the sponsor identify sufficient sites with patient recruitment ability to finish the trial on schedule.  

Last month, I helped a top 10 global pharmaceutical company find a CNS specialty Phase 1 unit with access to a large database of active and screened subjects and CNS patients for its Preferred Vendor Program.

ttambling@pharmaservicesnet.com          +1 803 746 4092

 

 

Dick Tully, Business Development ManagerDick Tully

Expertise: Generic Drug Development and Phase 2 - 4 Clinical Trials

My CRO client had two successful FDA audits in 2008.  Their BA / BE expertise includes routine dosing of females (both post menopausal and child bearing age) which is rare in India due to cultural issues.   Their BA / BE studies also include clinical endpoints and special patient populations.  In addition to a friendly regulatory environment, cost savings compared to USA CRO’s averages 30% to 40% which will enable you to bring more compounds to market.

Most recently, I have been contracted to develop their Phase 2 - 4 program.  Our experience includes over 200 clinical investigators across 110 research sites.

dtully@pharmaservicesnet.com          +1 803 746 4072